1 | annual | 3,654 |
2 | extra | 1,327 |
3 | on-treatment | 535 |
4 | age-specific | 327 |
5 | annualized | 237 |
6 | on-study | 102 |
7 | end-of-study | 100 |
8 | wholesale | 71 |
9 | in-trial | 69 |
10 | annualised | 63 |
11 | aptima | 49 |
12 | age-stratified | 43 |
13 | short-interval | 42 |
14 | enantiomerically | 35 |
15 | on-trial | 28 |
16 | on-therapy | 27 |
17 | undiscounted | 27 |
18 | in-study | 18 |
19 | per-capita | 18 |
20 | community-specific | 15 |
21 | on-clopidogrel | 15 |
22 | charge/discharge | 13 |
23 | class-i | 12 |
24 | intersystem | 12 |
25 | per-person | 12 |
26 | am/pm | 10 |
27 | hour-long | 10 |
28 | uncensored | 10 |
29 | rtv-boosted | 8 |
30 | singlet-triplet | 8 |
31 | intra-tracheal | 7 |
32 | postangioplasty | 7 |
33 | drg-based | 6 |
34 | guideline-compliant | 6 |
35 | neighbourhood-level | 6 |
36 | per-participant | 6 |
37 | per-subject | 6 |
38 | population-adjusted | 6 |
39 | vdj | 6 |
40 | adult-sized | 5 |
41 | idiotypic | 5 |
42 | leukocyte-filtered | 5 |
43 | post-rehabilitative | 5 |
44 | postwashout | 5 |
45 | test/ | 5 |
46 | 66-item | 4 |
47 | astronomical | 4 |
48 | cxcl16-induced | 4 |
49 | erlotinib-related | 4 |
50 | literature-derived | 4 |
51 | quadrennial | 4 |
52 | tomoh | 4 |
53 | 'genetic | 3 |
54 | case-related | 3 |
55 | i-cat | 3 |
56 | inr-specific | 3 |
57 | isovolumetrically | 3 |
58 | post-prophylactic | 3 |
59 | pressure-ulcer | 3 |
60 | provider-incurred | 3 |
61 | sis-related | 3 |
62 | syringe/needle | 3 |
63 | time-appropriate | 3 |
64 | unstabilized | 3 |
65 | vertical-loading | 3 |
66 | 10-beat | 2 |
67 | 2.3-mm | 2 |
68 | 20/40-20/320 | 2 |
69 | 4.9+/-1.6 | 2 |
70 | algae-based | 2 |
71 | asntr | 2 |
72 | autochtonous | 2 |
73 | azapeptide | 2 |
74 | bed-occupancy | 2 |
75 | canadian-specific | 2 |
76 | diet-dependent | 2 |
77 | endometriosis-specific | 2 |
78 | eto-sterilized | 2 |
79 | film-based | 2 |
80 | florbetapir | 2 |
81 | hrt-associated | 2 |
82 | information-probe | 2 |
83 | infusible | 2 |
84 | postplacement | 2 |
85 | pre-hifu | 2 |
86 | regioisomerically | 2 |
87 | '2l | 1 |
88 | 08mg | 1 |
89 | 1/2-day | 1 |
90 | 117±40 | 1 |
91 | 2.2-visit | 1 |
92 | 26-minute | 1 |
93 | 7,296 | 1 |
94 | accuration | 1 |
95 | achondroplastic | 1 |
96 | acoustic/disturbance | 1 |
97 | agglomeration-free | 1 |
98 | all-india | 1 |
99 | antidense | 1 |
100 | anxiety-agitation | 1 |
101 | atmospheric-warming-induced | 1 |
102 | bleeding.prophylactic | 1 |
103 | catheter-blocking | 1 |
104 | cocontracted | 1 |
105 | commercially-important | 1 |
106 | coronarins | 1 |
107 | cumbu | 1 |
108 | early/immediate | 1 |
109 | eibsee | 1 |
110 | extra-cephalic | 1 |
111 | frequency-low | 1 |
112 | gel-to-liquid | 1 |
113 | greenhouse-intensive | 1 |
114 | hcort-induced | 1 |
115 | impact-factor | 1 |
116 | increased/no | 1 |
117 | intranetwork | 1 |
118 | ip+intravenous | 1 |
119 | irf4-dusp22 | 1 |
120 | juga | 1 |
121 | kangdong | 1 |
122 | limit-ordered | 1 |
123 | mabs-treated | 1 |
124 | mass-spawning | 1 |
125 | maximum-force | 1 |
126 | meddiet+extra | 1 |
127 | microfluidics-generated | 1 |
128 | nambar | 1 |
129 | natricine | 1 |
130 | non-crop | 1 |
131 | nonwettable | 1 |
132 | normosol | 1 |
133 | ornate | 1 |
134 | panton | 1 |
135 | pedigree-derived | 1 |
136 | pk-curve | 1 |
137 | pneumatic-cart | 1 |
138 | polyinosinic‑polycytidylic | 1 |
139 | pupative | 1 |
140 | resection.the | 1 |
141 | resources-the | 1 |
142 | runted | 1 |
143 | sds-page/ | 1 |
144 | six.patients | 1 |
145 | studies.pregnancy | 1 |
146 | subjunctive | 1 |
147 | suboscine | 1 |
148 | subvalent | 1 |
149 | un-modified | 1 |
150 | vdm-fed | 1 |
151 | zipcode-level | 1 |
1 | '2l | 1 |
2 | 'genetic | 3 |
3 | 08mg | 1 |
4 | 1/2-day | 1 |
5 | 10-beat | 2 |
6 | 117±40 | 1 |
7 | 2.2-visit | 1 |
8 | 2.3-mm | 2 |
9 | 20/40-20/320 | 2 |
10 | 26-minute | 1 |
11 | 4.9+/-1.6 | 2 |
12 | 66-item | 4 |
13 | 7,296 | 1 |
14 | accuration | 1 |
15 | achondroplastic | 1 |
16 | acoustic/disturbance | 1 |
17 | adult-sized | 5 |
18 | age-specific | 327 |
19 | age-stratified | 43 |
20 | agglomeration-free | 1 |
21 | algae-based | 2 |
22 | all-india | 1 |
23 | am/pm | 10 |
24 | annual | 3,654 |
25 | annualised | 63 |
26 | annualized | 237 |
27 | antidense | 1 |
28 | anxiety-agitation | 1 |
29 | aptima | 49 |
30 | asntr | 2 |
31 | astronomical | 4 |
32 | atmospheric-warming-induced | 1 |
33 | autochtonous | 2 |
34 | azapeptide | 2 |
35 | bed-occupancy | 2 |
36 | bleeding.prophylactic | 1 |
37 | canadian-specific | 2 |
38 | case-related | 3 |
39 | catheter-blocking | 1 |
40 | charge/discharge | 13 |
41 | class-i | 12 |
42 | cocontracted | 1 |
43 | commercially-important | 1 |
44 | community-specific | 15 |
45 | coronarins | 1 |
46 | cumbu | 1 |
47 | cxcl16-induced | 4 |
48 | diet-dependent | 2 |
49 | drg-based | 6 |
50 | early/immediate | 1 |
51 | eibsee | 1 |
52 | enantiomerically | 35 |
53 | end-of-study | 100 |
54 | endometriosis-specific | 2 |
55 | erlotinib-related | 4 |
56 | eto-sterilized | 2 |
57 | extra | 1,327 |
58 | extra-cephalic | 1 |
59 | film-based | 2 |
60 | florbetapir | 2 |
61 | frequency-low | 1 |
62 | gel-to-liquid | 1 |
63 | greenhouse-intensive | 1 |
64 | guideline-compliant | 6 |
65 | hcort-induced | 1 |
66 | hour-long | 10 |
67 | hrt-associated | 2 |
68 | i-cat | 3 |
69 | idiotypic | 5 |
70 | impact-factor | 1 |
71 | in-study | 18 |
72 | in-trial | 69 |
73 | increased/no | 1 |
74 | information-probe | 2 |
75 | infusible | 2 |
76 | inr-specific | 3 |
77 | intersystem | 12 |
78 | intra-tracheal | 7 |
79 | intranetwork | 1 |
80 | ip+intravenous | 1 |
81 | irf4-dusp22 | 1 |
82 | isovolumetrically | 3 |
83 | juga | 1 |
84 | kangdong | 1 |
85 | leukocyte-filtered | 5 |
86 | limit-ordered | 1 |
87 | literature-derived | 4 |
88 | mabs-treated | 1 |
89 | mass-spawning | 1 |
90 | maximum-force | 1 |
91 | meddiet+extra | 1 |
92 | microfluidics-generated | 1 |
93 | nambar | 1 |
94 | natricine | 1 |
95 | neighbourhood-level | 6 |
96 | non-crop | 1 |
97 | nonwettable | 1 |
98 | normosol | 1 |
99 | on-clopidogrel | 15 |
100 | on-study | 102 |
101 | on-therapy | 27 |
102 | on-treatment | 535 |
103 | on-trial | 28 |
104 | ornate | 1 |
105 | panton | 1 |
106 | pedigree-derived | 1 |
107 | per-capita | 18 |
108 | per-participant | 6 |
109 | per-person | 12 |
110 | per-subject | 6 |
111 | pk-curve | 1 |
112 | pneumatic-cart | 1 |
113 | polyinosinic‑polycytidylic | 1 |
114 | population-adjusted | 6 |
115 | post-prophylactic | 3 |
116 | post-rehabilitative | 5 |
117 | postangioplasty | 7 |
118 | postplacement | 2 |
119 | postwashout | 5 |
120 | pre-hifu | 2 |
121 | pressure-ulcer | 3 |
122 | provider-incurred | 3 |
123 | pupative | 1 |
124 | quadrennial | 4 |
125 | regioisomerically | 2 |
126 | resection.the | 1 |
127 | resources-the | 1 |
128 | rtv-boosted | 8 |
129 | runted | 1 |
130 | sds-page/ | 1 |
131 | short-interval | 42 |
132 | singlet-triplet | 8 |
133 | sis-related | 3 |
134 | six.patients | 1 |
135 | studies.pregnancy | 1 |
136 | subjunctive | 1 |
137 | suboscine | 1 |
138 | subvalent | 1 |
139 | syringe/needle | 3 |
140 | test/ | 5 |
141 | time-appropriate | 3 |
142 | tomoh | 4 |
143 | un-modified | 1 |
144 | uncensored | 10 |
145 | undiscounted | 27 |
146 | unstabilized | 3 |
147 | vdj | 6 |
148 | vdm-fed | 1 |
149 | vertical-loading | 3 |
150 | wholesale | 71 |
151 | zipcode-level | 1 |
1 | sds-page/ | 1 |
2 | test/ | 5 |
3 | 20/40-20/320 | 2 |
4 | 117±40 | 1 |
5 | irf4-dusp22 | 1 |
6 | 4.9+/-1.6 | 2 |
7 | 7,296 | 1 |
8 | juga | 1 |
9 | all-india | 1 |
10 | aptima | 49 |
11 | extra | 1,327 |
12 | meddiet+extra | 1 |
13 | per-capita | 18 |
14 | age-specific | 327 |
15 | canadian-specific | 2 |
16 | inr-specific | 3 |
17 | endometriosis-specific | 2 |
18 | community-specific | 15 |
19 | extra-cephalic | 1 |
20 | polyinosinic‑polycytidylic | 1 |
21 | idiotypic | 5 |
22 | post-prophylactic | 3 |
23 | bleeding.prophylactic | 1 |
24 | 'genetic | 3 |
25 | achondroplastic | 1 |
26 | cxcl16-induced | 4 |
27 | atmospheric-warming-induced | 1 |
28 | hcort-induced | 1 |
29 | vdm-fed | 1 |
30 | un-modified | 1 |
31 | age-stratified | 43 |
32 | limit-ordered | 1 |
33 | leukocyte-filtered | 5 |
34 | uncensored | 10 |
35 | provider-incurred | 3 |
36 | algae-based | 2 |
37 | drg-based | 6 |
38 | film-based | 2 |
39 | annualised | 63 |
40 | mabs-treated | 1 |
41 | hrt-associated | 2 |
42 | erlotinib-related | 4 |
43 | case-related | 3 |
44 | sis-related | 3 |
45 | microfluidics-generated | 1 |
46 | cocontracted | 1 |
47 | undiscounted | 27 |
48 | runted | 1 |
49 | rtv-boosted | 8 |
50 | population-adjusted | 6 |
51 | pedigree-derived | 1 |
52 | literature-derived | 4 |
53 | annualized | 237 |
54 | unstabilized | 3 |
55 | eto-sterilized | 2 |
56 | adult-sized | 5 |
57 | gel-to-liquid | 1 |
58 | information-probe | 2 |
59 | acoustic/disturbance | 1 |
60 | maximum-force | 1 |
61 | azapeptide | 2 |
62 | agglomeration-free | 1 |
63 | eibsee | 1 |
64 | charge/discharge | 13 |
65 | resources-the | 1 |
66 | resection.the | 1 |
67 | wholesale | 71 |
68 | nonwettable | 1 |
69 | infusible | 2 |
70 | syringe/needle | 3 |
71 | natricine | 1 |
72 | suboscine | 1 |
73 | antidense | 1 |
74 | early/immediate | 1 |
75 | time-appropriate | 3 |
76 | ornate | 1 |
77 | 26-minute | 1 |
78 | greenhouse-intensive | 1 |
79 | pupative | 1 |
80 | post-rehabilitative | 5 |
81 | subjunctive | 1 |
82 | pk-curve | 1 |
83 | 08mg | 1 |
84 | vertical-loading | 3 |
85 | catheter-blocking | 1 |
86 | mass-spawning | 1 |
87 | kangdong | 1 |
88 | hour-long | 10 |
89 | tomoh | 4 |
90 | class-i | 12 |
91 | vdj | 6 |
92 | intranetwork | 1 |
93 | '2l | 1 |
94 | astronomical | 4 |
95 | intra-tracheal | 7 |
96 | quadrennial | 4 |
97 | in-trial | 69 |
98 | on-trial | 28 |
99 | annual | 3,654 |
100 | short-interval | 42 |
101 | on-clopidogrel | 15 |
102 | neighbourhood-level | 6 |
103 | zipcode-level | 1 |
104 | normosol | 1 |
105 | 66-item | 4 |
106 | intersystem | 12 |
107 | 2.3-mm | 2 |
108 | am/pm | 10 |
109 | accuration | 1 |
110 | anxiety-agitation | 1 |
111 | per-person | 12 |
112 | panton | 1 |
113 | increased/no | 1 |
114 | non-crop | 1 |
115 | nambar | 1 |
116 | pressure-ulcer | 3 |
117 | florbetapir | 2 |
118 | impact-factor | 1 |
119 | asntr | 2 |
120 | coronarins | 1 |
121 | six.patients | 1 |
122 | ip+intravenous | 1 |
123 | autochtonous | 2 |
124 | i-cat | 3 |
125 | 10-beat | 2 |
126 | per-subject | 6 |
127 | singlet-triplet | 8 |
128 | 2.2-visit | 1 |
129 | guideline-compliant | 6 |
130 | per-participant | 6 |
131 | commercially-important | 1 |
132 | diet-dependent | 2 |
133 | subvalent | 1 |
134 | postplacement | 2 |
135 | on-treatment | 535 |
136 | pneumatic-cart | 1 |
137 | postwashout | 5 |
138 | cumbu | 1 |
139 | pre-hifu | 2 |
140 | frequency-low | 1 |
141 | 1/2-day | 1 |
142 | studies.pregnancy | 1 |
143 | bed-occupancy | 2 |
144 | end-of-study | 100 |
145 | in-study | 18 |
146 | on-study | 102 |
147 | enantiomerically | 35 |
148 | regioisomerically | 2 |
149 | isovolumetrically | 3 |
150 | on-therapy | 27 |
151 | postangioplasty | 7 |